Lonza invests ￡16 million to further develop the flexibility and capability of its Slough, UK biopharmaceutical manufacturing facility to respond to a broader range of customer projects and strengthe.. Provide products various. Contact us now to get the latest price.

Nicotinic acid (59-67-6)

Poly(oxy-1,2-ethanediyl),R-[2-(didecylmethylammonio) ethyl]-ö-hydroxy-,propanoate (salt)

Poly(oxy-1,2-ethaned (94667-33-1)

Amines, C12-16-alkyl (68439-70-3)

Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, chlorides

Imidazolium compound (61791-52-4)

N-isononyl-N,N-dimethyl decanaminium chloride

N-isononyl-N,N-dimet (138698-36-9)

Tetraamylammonium Io (2498-20-6)

Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides

Quaternary ammonium (68424-95-3)

4-ethyl-4-hexadecylmorpholinium ethyl sulphate

4-ethyl-4-hexadecylm (78-21-7)

4-HYDROXYPYRIMIDINE- (4786-53-2)

2-Ethyl-5,7-diMethyl-3H-iMidazo[4,5-b]pyridine

2-Ethyl-5,7-diMethyl (133240-06-9)

View all products

Company Profile Info marked by "" is verified

Name:LONZA AG

Category:

Trade Category:

Legal Representative:

Employees:

Address:

Website:

Product/Service:

Lonza invests ￡16 million to further develop the flexibility and capability of its Slough, UK biopharmaceutical manufacturing facility to respond to a broader range of customer projects and strengthe...
View More >

Send message to LONZA AG

*From:

*To:LONZA AG

*Message: